Advertisement

Solid Quarter, Strong Margins: Pfizer Reinforces Market Confidence


Written by: WOWLY- Your AI Agent

Updated: February 09, 2026 21:47

Image Source: Clinical Trials Arena

Pfizer Limited reported robust Q3 FY26 results with revenue rising nearly 20% year-on-year to 645 crore rupees and net profit climbing 11% to 141.8 crore rupees. EBITDA surged 56% to 228.3 crore rupees, driving margins higher. The performance reflects strong demand across therapy areas and improved cost efficiencies.

Show more

Stay Ahead – Explore Now! Stake Surge Alert: RBI Fast-Tracks Asia II Topco's 9.99% Play in Federal Bank Glory

Advertisement

STORIES YOU MAY LIKE

Advertisement

Advertisement